echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Anti-infective drugs are used in the frail elderly population, pay attention to these safety issues!

    Anti-infective drugs are used in the frail elderly population, pay attention to these safety issues!

    • Last Update: 2023-01-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Multidosing in frail older adults is associated with
    increased serious adverse events (falls, cognitive impairment, functional decline, prolonged hospital stay, and risk of rehospitalization and death).
    The purpose of the Chinese Expert Consensus on the Safety Management of Multimedication in the Frail Elderly in Integrated Medical and Nursing Care Institutions (2022 Edition) is to guide the early screening, assessment, management and individualized comprehensive intervention
    of adverse reactions caused by multiple medication in the frail elderly in integrated medical and nursing care institutions.
    Regarding the use of anti-infective drugs for the frail elderly, the consensus mainly puts forward the following safety warnings
    .








    Safety warning of anti-infective drugs in frail elderly







    ➤ Antibacterial antibiotics


    Penicillin drugs should not be combined with telmicocin, chloramphenicol, erythromycin, sulfonamides, etc.
    ; Penicillin combined with warfarin can increase the effect of anticoagulants and increase the risk of bleeding, which should be monitored
    .


    Cephalosporins are equivalent to strong diuretics (furosemide, edinylic acid, bumetanide, etc.
    ), antineoplastic drugs (carzozac, streptocin, etc.
    ) and aminoglycoside antibiotics, which can increase nephrotoxicity; In combination with polymyxin E, polymyxin B and vancomycin, nephrotoxicity can be aggravated; In combination with non-steroidal anti-inflammatory analgesics, antiplatelet drugs, etc.
    , platelet inhibition is enhanced and the risk of
    bleeding is increased.


    Cephalosporins, metronidazole, β-endophthalamines are taken at the same time as alcohol, due to acetaldehyde accumulation, resulting in disulfiram reaction, severe blood pressure drop and even shock
    .


    β-endophthalamine drugs combined with strong diuretics such as furosemide can increase nephrotoxicity; In combination with heparin and warfarin, it increases the risk of
    bleeding.


    Aminoglycosides combined with plasma substitutes (dextran), diuretics (furosemide), erythromycin and capreomycin, cisplatin, vancomycin, norvancomycin, etc.
    , can increase ototoxicity and nephrotoxicity, causing hearing damage; Combination with polymyxins can also increase nephrotoxicity; In combination with diazepam, benzodiazepine, quinidine, etc.
    , it can lead to muscle weakness, respiratory depression or respiratory muscle paralysis
    .


    Macrolides, such as azithromycin, clarithromycin, etc.
    , are combined with carbamazepine, cyclosporine, digoxin, tacrolimus, phenytoin, afentanib, cisapride , disopyramide, lovastatin, bromocriptine, sodium valproate, etc.
    , and are prone to adverse reactions; In combination with terfenadine and asimizole, the electrocardiogram Q-T interval is prolonged, and torsades de pointes are prone to occur; In combination with lovastatin, the risk of rhabdomyolysis increases; In combination with warfarin (long-term use), it increases the risk of
    bleeding.


    Fluoroquinolones combined with theophylline drugs are easy to cause theophylline poisoning; It should not be used with drugs containing aluminum and magnesium and calcium, iron and zinc; Combination with nonsteroidal anti-inflammatory drugs (eg, indomethacin, ibuprofen, piroxicam) will produce drug antagonism; In combination with rifampicin and nitrofurantoin, it can antagonize the pharmacological effects of fluoroquinols; When combined with calcium channel blockers (nifenopyridine), it will affect the blood concentration of fluoroquinolones; In combination with sucralfate and antacids, the absorption rate of fluoroquinolones can be slowed down by 25%; With alkaline drugs, anticholinergics, and H2 receptor antagonists (such as ranitidine, famotidine, cimetidine, etc.
    ), it can slow the excretion of fluoroquinolones and easily form drug accumulation
    .


    ➤ Antifungal drugs


    Amphotericin B in combination with aminoglycosides can increase nephrotoxic effects; In combination with amiodarone, asimizole, quinidine, sotalol, sparfloxacin, sutopride ride, terfenadine, vincamine, etc.
    , it can cause hypokalemia, ECG Q-T interval prolongation leading to torsades de pointes, bradycardia, etc.
    ; In combination with digitalis, hypokalemia is easy to cause digitalis poisoning
    .


    Fluconazole in combination with oral warfarin increases the risk of bleeding; In combination with sulfonylurea hypoglycemic drugs, hypoglycemia is prone to occur; In combination with theophylline and aminophylline, it can increase the blood concentration of theophylline and increase the risk
    .


    Itraconazole, ketoconazole, miconazole combined with warfarin increases the risk of bleeding; In combination with astimazole, terfenadine, cisapride increases the risk of ventricular arrhythmias (torsades de pointes); In combination with digoxin, it can increase the concentration of digoxin and cause digoxin poisoning; In combination with midazolam and triazolam, it significantly enhances its sedative effect
    .


    Ketoconazole combined with ethanol or drinking strong liquor can cause disulfiram-like effects, so concomitant use of alcoholic beverages and drugs
    should be avoided.


    Click to read the original consensus article


    The above content is excerpted from: "Chinese Expert Consensus on the Safety Management of Multiple Drugs for the Frail Elderly in Integrated Medical and Nursing Care Institutions (Edition)" Writing Group, Chinese Geriatric Society Integrated Medical and Nursing Care Promotion Committee.
    Chinese expert consensus on the safety management of multiple drugs in the frail elderly in integrated medical and nursing care institutions (2022 edition)[J].
    Chinese Journal of Cardiovascular Disease,2022,27(5):403-410.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.